Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ripretinib Tablets

Approval Number

国药准字HJ20210022

CompanyDeciphera Pharmaceuticals, LLC

Registration Date

March 30, 2021

Drug Information

Generic Name

瑞派替尼片

Trade Name

擎乐

Dosage Form

片剂

Strength

50mg (C₂₄H₂₁BrFN₅O₂)

Drug Type

化学药品

Registration Date

March 30, 2021

Expiry Date

March 29, 2026

Company Information

Applicant Company

Company NameDeciphera Pharmaceuticals, LLC

Company Address

200 Smith Street, Waltham, MA 02451 United States of America

Manufacturing Company

Company NameLONZA BEND INC.

Company Address

20503 Builders St, Bend, OR 97701 United States of America

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy